Analyst firms · BofA Securities · STNG
BofA Securities STNG price target and rating history
Scorpio Tankers Inc. (STNG) · Consumer Discretionary
BofA Securities rates Scorpio Tankers Inc. (STNG) Underperform with a $78 price target, as of its latest action on Jun 30, 2026. It has published 9 rating actions on STNG since August 2021, including 5 upgrades and 4 downgrades. Across 3 firms with a STNG price target in the last 12 months, the median target is $82. BofA Securities's $78 is 5% below that.
- Current rating
- Underperform
- Price target
- $78
- Median target, all firms
- $82
- Actions on STNG
- 9
BofA Securities price target on STNG
Every BofA Securities rating on STNG
- Jun 30, 2026
- May 7, 2026
- Jan 9, 2026
- Sep 8, 2025
- Jul 21, 2023
- Mar 3, 2022
- Feb 10, 2022
- Feb 10, 2022
- Aug 5, 2021
How other firms rate STNG
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | $82 | Jul 9, 2026 |
| BofA Securities | Underperform | $78 | Jun 30, 2026 |
| Jefferies | Buy | $90 | Apr 24, 2026 |
Questions about BofA Securities and STNG
- What is BofA Securities's price target for STNG?
- BofA Securities's latest stated price target for Scorpio Tankers Inc. (STNG) is $78, from its action on Jun 30, 2026.
- What is BofA Securities's rating on STNG?
- BofA Securities rates STNG Underperform, a bearish rating, as of Jun 30, 2026.
- When did BofA Securities last change its view on STNG?
- On Jun 30, 2026, BofA Securities downgrades to Underperform from Buy, price target $78.
- How does BofA Securities's STNG target compare with other analysts?
- Across 3 firms with a STNG price target in the last 12 months, the median target is $82. BofA Securities's $78 is 5% below that.
More STNG rating histories
All BofA Securities ratingsSTNG news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.